AMAYA EYE-PAEDIATRICS LIMITED

💤Zombieactive
SC499845 · ltd · incorporated 2015-03-06
Investment thesis
Zombie company — trading but stalled; unlikely mover.
Why interesting: Quiet, steady; could be a succession or carve-out candidate with the right conversation.
Why risky: No growth signal; thin margin for error on price.
🔒Estimated value
—
Upgrade to see
Turnover
—
year to Mar 2025
Net worth
£90.6k
book net assets
Opportunity
78/100
Strong
🔔
Follow this company (free)
Email alerts on filings, charges, director changes, gazette notices. No account needed.

Unsubscribe any time from any email. GDPR-respectful.

🔒Generate AI memo →🔒Outreach pack →🔒Corporate story →📑 Reports →Sign in to watch
What this business does
Primary activity: Specialist medical practice activities
Sector: Human health & social work
Investor take
Pursue
Asset-holding vehicle with a 66-year-old founder — textbook succession opportunity.

Opportunity 78/100 (strong), bankability 75/100. Strong seller-intent signal (68/100, director aged 66). Share purchase looks the cleaner deal structure. Biggest value-creation lever: Broaden director team. Sole director creates succession risk and reduces buyer comfort. Appoint a second director or strong #2. Most likely exit: share sale to pe / searcher (73/100).

Data confidence

Overall: medium (78/100)

Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.

Company profile
address, 1 SIC codes, incorporation date
100
Financials
2 years of iXBRL accounts extracted (YoY deltas available) + narrative notes parsed
75
Lenders & charges
Confirmed no charges registered
85
Directors & officers
1 officers (1 active, 1 linked, 1 with DOB)
90
Ownership & PSC
1 active PSC(s) of 1 total, 1 with control declared
90
Director network
Network not yet resolved
30
Filing history
25 filings on record
85
Gazette notices
No matching gazette notices (standard for active companies)
60
Opportunity Score
78/100Strong
PassWatchWorth a lookStrongExceptional 

Solid opportunity signal. Worth a dedicated memo and management meeting.

Business quality
70
Active, clean filings, stable charge profile.
Acquirability
70
Strong succession / seller-readiness signals.
Risk profile
85
Few red flags.
Signal strength
90
Good data coverage for analysis.

Signals from accounts

Derived from iXBRL accounts · FRS 102
Positive net assets
Net assets £90,635
Cash YoY
+7%
Year on year

Key financials

2 years extracted from filed iXBRL accounts
Cash
£95k
↑ 6.5% YoY
Net Worth
£91k
↑ 7.1% YoY
Current Assets
£95k
↑ 6.5% YoY
Current Liabilities
—
£0£19k£38k£57k£76k£95kMar 2024Mar 2025

Hover to see exact values · click legend to toggle series

Financials

Extracted from Companies House accounts · FRS 102
Metric2025-03-312024-03-31
Total assets£90.6k£84.6k
Current assets£94.9k£89.1k
Cash£94.9k£89.1k
Net assets£90.6k£84.6k

Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.

🔒Filing-note intelligence

1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.

Available from the Pro tier upwards.

See pricing →

Recent activity

Last 30 days
0
filings
Last 90 days
0
filings
Last 180 days
1
filing
  • • 1 accounts
Counts from Companies House filing history.
Corporate timeline (18 events)Click to expand
  1. 2025-12-19
    📄
    accounts-with-accounts-type-unaudited-abridged
    accounts · AA
  2. 2025-06-09
    📍
    change-registered-office-address-company-with-date-old-address-new-address
    address · AD01
  3. 2024-12-27
    📄
    accounts-with-accounts-type-unaudited-abridged
    accounts · AA
  4. 2023-12-30
    📄
    accounts-with-accounts-type-unaudited-abridged
    accounts · AA
  5. 2023-03-31
    📄
    accounts-with-accounts-type-unaudited-abridged
    accounts · AA
  6. 2021-12-28
    📄
    accounts-with-accounts-type-unaudited-abridged
    accounts · AA
  7. 2020-12-23
    📄
    accounts-with-accounts-type-unaudited-abridged
    accounts · AA
  8. 2019-12-29
    📄
    accounts-with-accounts-type-unaudited-abridged
    accounts · AA
  9. 2018-12-15
    📄
    accounts-with-accounts-type-unaudited-abridged
    accounts · AA
  10. 2017-12-22
    📄
    accounts-with-accounts-type-unaudited-abridged
    accounts · AA
  11. 2017-11-13
    📍
    change-registered-office-address-company-with-date-old-address-new-address
    address · AD01
  12. 2016-12-06
    📄
    accounts-with-accounts-type-total-exemption-small
    accounts · AA
  13. 2016-05-05
    📄
    annual-return-company-with-made-up-date-full-list-shareholders
    annual-return · AR01
  14. 2015-04-14
    📄
    change-person-director-company-with-change-date
    officers · CH01
  15. 2015-04-14
    📄
    annual-return-company-with-made-up-date-full-list-shareholders
    annual-return · AR01
  16. 2015-03-06
    🏢
    Company incorporated
    As AMAYA EYE-PAEDIATRICS LIMITED
  17. 2015-03-06
    ➕
    AMAYA PEDRAZA, Luis Guillermo, Dr appointed
    director
  18. 2015-03-06
    📄
    incorporation-company
    incorporation · NEWINC

Owner dependency

95/100
Critical — business is the founder

The business appears inseparable from the founder. Acquisition without a serious earn-out or meaningful transition period would likely destroy value.

FACTORS
  • +Sole director: Only one active director — all governance concentrated on one person.
  • +Founder age: Director aged approximately 66 — succession pressure is live.
  • +No director turnover: Company is 11 years old with no director changes — suggests a very tight-knit founder team never broadened.

Succession & seller-readiness

70/100
Strong succession signal

Multiple signals suggest succession is on the horizon. Candidate for proactive outreach.

SIGNALS
  • primaryFounder aged 63+: Senior director is approximately 66. Approaching typical UK retirement age — succession thinking likely.
  • primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.
  • supportingClean filings + long tenure: Disciplined long-tenure operator — classic lifestyle-business pattern that often sells quietly.

Red flags

clean
No red flags detected from available public data. (This is not a clean bill of health — detailed accounts review still recommended.)

Shareholders & ownership

1 active beneficial owner · dominant holder ≥75%
NameSharesVoting rightsNature of controlNotified
Dr Luis Guillermo Amaya Pedraza
Individual · British · DOB 03/1960 · age 66
75–100%
—75-100% shares06/04/2016

From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.

Similar companies

Active · Healthcare & medical · EH postcode area
CompanyEst. valueTurnoverNet worthStaffAgeOppDirector
ASKA PSYCHOLOGIST LTD→
SC743888 · est 2022 · no financials extracted
————3y——
ASPEN TOWER SILVERSTONE PROPCO (QVH) LIMITED→
SC603160 · est 2018 · no financials extracted
————7y——
AVODAH CARE LTD→
SC726265 · est 2022 · no financials extracted
————4y——
AZAD PHARMA LTD→
SC725723 · est 2022 · no financials extracted
————4y——
BALLANTINE GOLDIE LTD→
SC392228 · est 2011 · no financials extracted
————15y——
BELLEVUE DENTAL PRACTICE (EDINBURGH) LTD→
SC381652 · est 2010 · no financials extracted
————15y——
BELLEVUE OPTICAL LIMITED→
SC806451 · est 2024 · no financials extracted
————2y——
BELSIZE HEALTHCARE (SCOTLAND) LIMITED→
SC647885 · est 2019 · no financials extracted
————6y——
BELWOOD MEDICAL LIMITED→
SC775439 · est 2023 · no financials extracted
————2y——
BENILAVIS MEDICAL LTD→
SC653467 · est 2020 · no financials extracted
————6y——
BESPOKE CLINICAL CARE LTD→
SC515964 · est 2015 · no financials extracted
————10y——
BEST HEARING LIMITED→
SC748989 · est 2022 · no financials extracted
————3y——
Peers ranked by estimated value, then turnover, then opportunity score.See all →
🔒Tailored diligence questions

8 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.

Available from the Pro tier upwards.

See pricing →
🔒Advanced scoring suite

Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.

Available from the Pro tier upwards.

See pricing →

Company details

Statusactive
Typeltd
Incorporated2015-03-06
Jurisdictionscotland
Primary SIC86220 — Specialist medical practice activities

Registered office

15 Manor Place
Edinburgh
EH3 7DH
United Kingdom

Filing status

Accounts
Next due: 2026-12-31
Last made up to: 2025-03-31
Confirmation statement
Next due: 2026-04-28
Last: 2025-04-14

Officers (1 active · 0 resigned)

AMAYA PEDRAZA, Luis Guillermo, Dr→
director · ~66y · appointed 2015-03-06
View their other companies + combined net worth →
Active

Click a director name to see their full track record across all companies.

Recent filings (25 total)

accounts-with-accounts-type-unaudited-abridged
accounts · AA
2025-12-19
change-registered-office-address-company-with-date-old-address-new-address
address · AD01
2025-06-09
confirmation-statement-with-no-updates
confirmation-statement · CS01
2025-04-21
accounts-with-accounts-type-unaudited-abridged
accounts · AA
2024-12-27
confirmation-statement-with-no-updates
confirmation-statement · CS01
2024-04-26
accounts-with-accounts-type-unaudited-abridged
accounts · AA
2023-12-30
confirmation-statement-with-no-updates
confirmation-statement · CS01
2023-04-24
accounts-with-accounts-type-unaudited-abridged
accounts · AA
2023-03-31
confirmation-statement-with-no-updates
confirmation-statement · CS01
2022-05-09
accounts-with-accounts-type-unaudited-abridged
accounts · AA
2021-12-28
confirmation-statement-with-no-updates
confirmation-statement · CS01
2021-04-29
accounts-with-accounts-type-unaudited-abridged
accounts · AA
2020-12-23
confirmation-statement-with-no-updates
confirmation-statement · CS01
2020-04-28
accounts-with-accounts-type-unaudited-abridged
accounts · AA
2019-12-29
confirmation-statement-with-no-updates
confirmation-statement · CS01
2019-04-26